Halozyme Therapeutics Inc. (0J2O)
Market Closed
17 Jul, 15:30
$
77. 17
+0.04
+0.0519%
$
- Market Cap
20.87 P/E Ratio
- Div Yield
222 Volume
2.74 Eps
$ 77.13
Previous Close Want to track 0J2O and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Halozyme Therapeutics Inc. (0J2O) Statistics
Valuation metrics
Market Cap -
Enterprise value 11.06B
Trailing P/E (ttm) 26.65
Forward P/E -
PEG ratio -1.1
Price/Sales (ttm) 6.12
Price/Book (mrq) 41.85
Enterprise Value/Revenue 7.33
Enterprise Value/EBITDA 17.74
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 475
Average volume (90 days) 925
Price summary
52-Week low 56.01
52-Week high 84.23
Beta -
50-Day moving average 73.02
200-Day moving average 70.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 171:40
Last split Date 10 Dec 2003
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.23%
Operating margin 0.57%
Operational effectiveness
Return on assets 0.13%
Return on equity 1.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 12.77
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.7
Total debt (mrq) -
Total Debt/Equity (mrq) 9.76
Current ratio (mrq) 2.76%
Book value per share (mrq) 1.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
